BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 22 filers reported holding BIOPHARMX CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $669,000 | -2.0% | 7,595,092 | +20.0% | 0.00% | – |
| Q4 2018 | $683,000 | -29.6% | 6,328,195 | +23.9% | 0.00% | – |
| Q3 2018 | $970,000 | -14.0% | 5,106,504 | 0.0% | 0.00% | – |
| Q2 2018 | $1,128,000 | -11.2% | 5,106,504 | -7.1% | 0.00% | – |
| Q1 2018 | $1,270,000 | +490.7% | 5,498,918 | +181.0% | 0.00% | – |
| Q4 2017 | $215,000 | -61.6% | 1,956,947 | 0.0% | 0.00% | – |
| Q3 2017 | $560,000 | -39.6% | 1,956,947 | +1.2% | 0.00% | – |
| Q2 2017 | $927,000 | +303.0% | 1,933,747 | +324.6% | 0.00% | – |
| Q1 2017 | $230,000 | +130.0% | 455,409 | +71.9% | 0.00% | – |
| Q4 2016 | $100,000 | +14.9% | 264,885 | +70.2% | 0.00% | – |
| Q3 2016 | $87,000 | -13.0% | 155,626 | +0.8% | 0.00% | – |
| Q2 2016 | $100,000 | -40.5% | 154,426 | +0.3% | 0.00% | – |
| Q1 2016 | $168,000 | +115.4% | 154,009 | +199.7% | 0.00% | – |
| Q4 2015 | $78,000 | – | 51,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 14,096,338 | $6,752,000 | 1.70% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 58,027 | $28,000 | 0.01% |
| Virtu KCG Holdings LLC | 503,418 | $241,000 | 0.01% |
| Baker Brothers Advisors | 598,758 | $287,000 | 0.00% |
| Moors & Cabot, Inc. | 40,000 | $19,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,499,615 | $4,550,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11,385 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 323,967 | $155,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 22,718 | $11,000 | 0.00% |
| OPPENHEIMER & CO INC | 28,000 | $13,000 | 0.00% |